Longview Regional Medical Center in Texas co-hosted a “Play it Safe” event inviting teenagers across East Texas and surrounding areas to participate in free heart checkups. Now in its fifth year, the event was also hosted by Championship Hearts Foundation, a nonprofit that focuses on preventing sudden cardiac death among youth.

Tokyo-based Terumo Corporation has today announced an investment of £33 million in one of its subsidiary companies, Vascutek Limited, located near Glasgow.

Unfractionated heparin (UFH) has overtaken bivalirudin as the anticoagulant of choice for treating end-stage renal disease (ESRD) patients undergoing PCI, according to a new study, but UFH may be associated with worse in-hospital outcomes.

A plasma test to determine the maximum density of a blood clot and how long it takes to break down could help identify heart attack patients at increased risk for cardiovascular death or another myocardial infarction (MI), according to a study published Jan. 29 in the European Heart Journal.

Low-income parents may not be able to afford a new iPad for their child, but they can buy them a $1 bag of potato chips or a soda. With that purchase, they get the rare chance to say “yes” to their kid, a Stanford University doctoral candidate wrote in the Los Angeles Times.

US News & World Report issued their rankings for the top 10 hospitals for pediatric cardiology and heart surgery in the country.

New research published in the Journal of the American Medical Association suggests a patent foramen ovale (PFO), colloquially known as a hole in the heart, can double the risk of stroke within 30 days of non-cardiac surgery.

COPENHAGEN, February 8, 2018 — Acesion Pharma ("Acesion" or the Company), a Danish biotech company developing novel treatments for atrial fibrillation (AF), the most common cardiac arrhythmia, announces today it has received approval to commence its first clinical study for its lead compound AP30663. The phase 1 study in healthy subjects will be conducted at the Centre for Human Drug Research (CHDR) in the Netherlands and is due to start in March 2018.